Migraine%20headache Diagnosis
Classification
Diagnostic Criteria
Migraine Headache without Aura1
- At least 5 attacks with any 2 of the following headache characteristics and should last from 4-72 hours without treatment or had unsuccessful treatments:
- Unilateral
- Throbbing or pulsating in nature
- Pain is considered moderate to severe
- Usual physical activity (eg walking or climbing stairs) aggravates pain
- Plus any one of the following symptoms:
- Nausea and/or vomiting
- Photophobia and phonophobia
- Headache is not better accounted for by another International Classification of Headache Disorders (ICHD)-3 diagnosis
Migraine Headache with Aura1
- Headache with accompanying or preceding transient focal neurological symptoms
- At least 2 attacks with ≥1 of the following fully reversible aura symptoms:
- Visual symptoms including positive features (flickering lights, spots or lines) and/or negative features (loss of vision)
- Sensory symptoms including positive features (pins and needles) and/or negative features (numbness)
- Speech and/or language (eg dysphasic speech disturbance)
- Motor
- Brainstem
- Retinal
- At least 3 of the following characteristics:
- At least 1 aura symptom develops gradually over ≥5 minutes
- ≥2 aura symptoms that occur in succession
- Every aura symptom lasts 5-60 minutes (if 3 symptoms occur during an aura, 3 x 60 minutes is the acceptable maximum duration; motor symptoms can last up to 72 hours)
- ≥1 unilateral aura symptom (eg aphasia)
- ≥1 positive aura symptom (eg scintillations and pins and needles)
- Headache occurs with the aura or 60 minutes after the aura
- Headache is not better accounted for by another ICHD-3 diagnosis
Chronic Migraine1
- Headache (tension-type-like or migraine-like) occurring for ≥15 days per month for >3 months with the following characteristics:
- Attacks last for 4-72 hours (without treatment or had unsuccessful treatment)
- ≥2 of the following features are present: Unilateral location, pulsating quality, pain is moderate or severe in intensity, aggravated by or resulting to avoidance of routine physical activity (eg walking or climbing stairs)
- ≥5 attacks fulfilling the following criteria:
- Presence of headache with ≥2 of the 4 characteristics mentioned in the above diagnostic criteria for migraine headache without aura plus during headache there is a presence of 1 of the symptoms mentioned in the above criteria for migraine headache without aura
- Presence of ≥1 fully reversible aura symptoms enumerated in the above diagnostic criteria for migraine headache with aura plus ≥3 of the characteristics mentioned in the above criteria for migraine headache with aura
- On ≥8 days/month for >3 months, the patient has any of the following characteristics:
- Presence of headache with ≥2 of the characteristics mentioned in the above diagnostic criteria for migraine headache without aura plus having 1 of the following during headache: Nausea and/or vomiting or photophobia and phonophobia
- Presence of ≥1 fully reversible aura symptoms enumerated in the above diagnostic criteria for migraine headache with aura plus ≥3 of the characteristics mentioned in the above criteria for migraine headache with aura
- Believed by the patient to be migraine at onset and relieved by a triptan or ergot derivative
- Headache is not better accounted for by another ICHD-3 diagnosis
Diagnosis
Status Migrainosus
- Usually severe and debilitating migraine headache that requires aggressive treatment
- Often caused by medication (eg analgesic) overuse
- Treatment may start with intravenous fluids and electrolyte replacement if indicated
- Some patients may need hospitalization for rehydration, control of vomiting by giving antiemetics and abortive therapy
- Abortive therapy includes parenteral triptan without ergot and/or Dihydroergotamine 8-12 hours after the last dosage of triptan
- Ketorolac intramuscular/intravenous or sodium valproate can be given if Dihydroergotamine or triptan is contraindicated or ineffective
Evaluation
- Therapy decision is made based on severity of headache
Severity Categories
Moderate
- Patient is not completely incapacitated but daily activities are greatly hindered by headache
Severe
- Patient’s daily activities are not performed or they are greatly altered because of headache
Status migrainosus
- Severe headache that lasts >72 hours
Evaluation to determine if patient should receive migraine prophylactic treatment
- When indicated, prophylactic treatment should be used in addition to acute therapy
Indication for prophylactic therapy may be based on:
- Frequency of attacks is ≥4 days per month
- Patients feel that migraines are significantly interfering with their normal daily activities even with acute treatment lasting for ≥4 days per month
- Failure and contraindication of acute therapies
- Overuse of acute therapy defined as:
- ≥10 days per month for combination analgesics, ergot derivatives, opioids, triptans, and a combination of drugs from different classes that are not individually overused
- ≥15 days per month for Paracetamol, non-opioid analgesics and nonsteroidal anti-inflammatory drugs (NSAIDs) including Aspirin
- Adverse effects from acute therapies
- Patient preference
- Menstrual migraine
- Cost of acute therapy
- Presence of neurologic damage from uncommon migraine types
- Duration of individual attacks >24 hours
Assessment
Initial assessment should include but is not limited to:
- Detailed history
- Headache characteristics (nature of pain, severity, location, frequency, duration)
- Functional impairment
- Assessment of impact on patient’s life and lifestyle is necessary for planning the best management and may be done using the Migraine Disability Assessment (MIDAS) instrument or Headache-attributed Lost Time (HALT) indices which estimates the total productive time lost due to the disabling effect of headache
- Accompanying symptoms
- Past medical history
- Family history of migraines
- Social history
- Medical history
- Thorough physical and neurological examination
Any of the following signs and symptoms may suggest secondary headache:
- Symptoms suggesting systemic illness (eg fever)
- Any other neurological signs or symptoms (focal or non-focal)
- Most severe headache ever experienced by patient
- Persistent or progressive worsening of headache
- Change in usual headache pattern
- Awakening of patient from sleep
- New onset in patient >50 years of age
- Valsalva maneuver (eg sneezing, coughing, bending forward or lying down or exertion) precipitates headache
- Seizures
- Maximum severity at onset of headache